Dr Jelle Klein graduated as Medical Doctor in 2016 from the University of Antwerp with a Master of Science in Medicine. Between 2016 and 2018, he specialized in Obstetrics and Gynecology in several hospitals in Belgium. In 2024, he was recognized as a board-certified Clinical Pharmacologist. In October 2018, Dr Klein joined the SGS Phase I unit as Principal Investigator, gaining experience in the coordination and set-up of phase 0-IV clinical trials (in different area’s as immunology, dermatology, cardiology, etc.) while being responsible of the safety and wellbeing of the subjects on site as well as the analysis of the clinical data. Since mid 2022, he is CPU Medical Director, and overall responsible for medical and scientific aspects of the CPU early phase projects.
